Rioux-Leclercq et al. reported that the expression of VEGF, assessed using IHC, in CCRCC tumors from 50 patients with a median follow-up of 11 months, was significantly associated with plasma VEGF levels, measured using an enzyme-linked immunoassay. Here, VEGFA is linked to nonpapillary renal cell carcinoma.